Laser vaporization for vulvar intraepithelial neoplasia III.
Eighteen women with vulvar intraepithelial neoplasia (VIN) III were treated with laser vaporization. The majority had multifocal disease. After a single laser vaporization, 15 of the 18 remained free of recurrent disease, with a mean follow-up of 129.5 weeks (range, 24-253). There were no intraoperative complications. Two patients had delayed healing and persistent vulvar soreness for 4 and 10 months. Laser vaporization appears to be reasonably well tolerated and effective for VIN III, especially multifocal.
Hoffman
M S
MS
Division of Obstetrics and Gynecology, University of South Florida, Tampa.
Pinelli
D M
DM
Finan
M
M
Roberts
W S
WS
Fiorica
J V
JV
Cavanagh
D
D
D000328:Adult; D002278:Carcinoma in Situ / Q000473:pathology / Q000601:surgery*; D005260:Female; D006801:Humans; D053685:Laser Therapy; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D014846:Vulvar Neoplasms / Q000473:pathology / Q000601:surgery*